Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

3.6K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
3.6K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

581
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
581
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

481
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
481
Relative Risk01:12

Relative Risk

866
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
866
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

441
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
441
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

218
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
218

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Computed tomography findings in 11,504 adult patients with traumatic brain injury: a large real-world cohort study with a S100B subgroup analysis.

Archives of orthopaedic and trauma surgery·2026
Same author

Preliminary Investigation of Federated Learning for MACE Prediction from Electronic Medical Records: A Multicontinental Study.

Studies in health technology and informatics·2026
Same author

The prospective Austrian hypertrophic cardiomyopathy registry - design, methods and results of the run-in period.

Heart failure reviews·2026
Same author

Destabilization of cardiac myosin acetylation and sequestration with type 2 diabetes mellitus.

Cardiovascular diabetology·2026
Same author

Development and validation of random-forest based federated ensemble learning algorithms for delirium prediction using electronic medical records from eleven hospitals in Austria: a retrospective study.

BMC medical informatics and decision making·2026
Same author

Negative predictive value of S100B in all types of traumatic brain injury in different aging groups.

BMC emergency medicine·2025

Related Experiment Video

Updated: Nov 6, 2025

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.5K

Machine Learning Based Risk Prediction for Major Adverse Cardiovascular Events.

Michael Schrempf1, Diether Kramer1, Stefanie Jauk1,2

  • 1Steiermärkische Krankenanstaltengesellschaft m. b. H., Graz, Austria.

Studies in Health Technology and Informatics
|May 9, 2021
PubMed
Summary

Machine learning models predict the 5-year risk of major adverse cardiovascular events (MACE) like heart attack and stroke. A random forest model showed excellent performance, identifying high-risk patients for early intervention.

Keywords:
Cardiovascular DiseasesCardiovascular RiskElectronic Medical RecordsMachine LearningMajor Adverse Cardiovascular EventsMyocardial InfarctionRisk AssessmentStroke

More Related Videos

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
07:25

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia

Published on: September 22, 2020

3.6K
Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

7.8K

Related Experiment Videos

Last Updated: Nov 6, 2025

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.5K
Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
07:25

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia

Published on: September 22, 2020

3.6K
Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

7.8K

Area of Science:

  • Cardiovascular medicine
  • Medical informatics
  • Machine learning in healthcare

Background:

  • Major adverse cardiovascular events (MACE), including myocardial infarction and stroke, lead to significant hospitalizations and mortality.
  • Early identification of at-risk patients is crucial for implementing preventive interventions.
  • Developing robust risk prediction tools is essential for improving patient outcomes.

Purpose of the Study:

  • To develop and evaluate machine learning models for predicting the 5-year risk of MACE.
  • To leverage electronic medical record data for comprehensive cardiovascular risk assessment.
  • To identify key features for accurate MACE prediction.

Main Methods:

  • Utilized electronic medical records from over 128,000 patients, with 29,262 diagnosed with MACE.
  • Applied feature selection techniques (filter and embedded methods) to identify 826 relevant features.
  • Trained and evaluated various machine learning models on the prepared dataset.

Main Results:

  • A random forest model demonstrated superior calibration and discriminative ability.
  • The best performing model achieved an Area Under the Receiver Operating Characteristic curve (AUROC) of 0.88 on a test dataset.
  • The models showed excellent predictive performance in the evaluated test data.

Conclusions:

  • The developed machine learning models exhibit excellent performance for 5-year MACE risk prediction.
  • Further prospective studies are required to validate the clinical utility and benefit of these models.
  • These models hold potential for early detection and prevention of cardiovascular events.